ALPINE IMMUNE SCIENCES, INC. Lease, Cost
ALPINE IMMUNE SCIENCES, INC. reported Lease, Cost of $2.76 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2024-03-20
- ALPINE IMMUNE SCIENCES, INC. lease, cost for the quarter ending 2019-12-31 was $758.00K.
- ALPINE IMMUNE SCIENCES, INC. lease, cost for the quarter ending 2019-09-30 was $774.00K.
- ALPINE IMMUNE SCIENCES, INC. lease, cost for the quarter ending 2019-06-30 was $445.00K.
- ALPINE IMMUNE SCIENCES, INC. lease, cost for the quarter ending 2019-03-31 was $298.00K.
- ALPINE IMMUNE SCIENCES, INC. lease, cost for fiscal 2023 was $2.76M, a 3.68% increase from fiscal 2022.
- ALPINE IMMUNE SCIENCES, INC. lease, cost for fiscal 2022 was $2.66M, a 9.10% increase from fiscal 2021.
- ALPINE IMMUNE SCIENCES, INC. lease, cost for fiscal 2021 was $2.44M, a 3.96% increase from fiscal 2020.
- ALPINE IMMUNE SCIENCES, INC. lease, cost for fiscal 2020 was $2.35M, a 3.16% increase from fiscal 2019.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2023-12-31 | $2.76M 10-K · filed 2024-03-20 | |||
| 2022-12-31 | $2.66M 10-K · filed 2024-03-20 | |||
| 2021-12-31 | $2.44M 10-K · filed 2024-03-20 | |||
| 2020-12-31 | $2.35M 10-K · filed 2023-03-23 | |||
| 2019-12-31 | $758.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $1.53M derived: sum of 2 quarters · filed 2021-03-18 | $1.98M derived: sum of 3 quarters · filed 2021-03-18 | $2.27M 10-K · filed 2021-03-18 |
| 2019-09-30 | $774.00K 10-Q · filed 2019-11-14 | $1.22M derived: sum of 2 quarters · filed 2019-11-14 | $1.52M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $445.00K 10-Q · filed 2019-08-13 | $743.00K 10-Q · filed 2019-08-13 | ||
| 2019-03-31 | $298.00K 10-Q · filed 2019-05-09 |